Skip to main content
Clinical Trials/IRCT20210403050815N1
IRCT20210403050815N1RecruitingPhase 3

Evaluation of the ?effect of Topical Intranasal Tranexamic Acid for Stopping Nose Bleeding in Patients with Epistaxis in the ENT Emergency Department

Shiraz University of Medical Sciences0 sites240 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Enrollment
240

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to no limit (—)
Sex
All

Inclusion Criteria

  • Aged 18 or over
  • Presenting to the Ear, Nose, and Throat emergency department (ED) with spontaneous, atraumatic anterior epistaxis, unresolved with simple first aid

Exclusion Criteria

  • Hemodynamically unstable
  • Known allergy to tranexamic acid
  • Lacking capacity or unwilling to give consent
  • Known nasopharyngeal, nasal cavity or paranasal malignancy
  • Already undergone prehospital nasal packing
  • Epistaxis caused by trauma (excluding simple nose picking)
  • Any Known bleeding disorders
  • Any recent use of anticoagulation drugs

Investigators

Similar Trials